§ 13F · FUND PROFILE
JOHNSON & JOHNSON.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $334.1T (13F)Positions · 20Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$191.8B deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | PTGX | Protagonist Therapeutics Inc. | 2.45M | $213.9T | 38.6% | ±0% |
| 2 | NBTX | Nanobiotix S.A. | 5.62M | $130.0T | 23.4% | ±0% |
| 3 | RAPP | Rapport Therapeutics, Inc. | 1.78M | $54.1T | 9.8% | ±0% |
| 4 | MGTX | MeiraGTx Holdings plc | 6.64M | $52.8T | 9.5% | ±0% |
| 5 | CVRX | CVRx, Inc. | 4.02M | $28.6T | 5.2% | −2% |
| 6 | CTNM | Contineum Therapeutics Inc. | 1.98M | $22.6T | 4.1% | ±0% |
| 7 | LEGN | Legend Biotech Corporation | 815K | $17.7T | 3.2% | ±0% |
| 8 | XNCR | Xencor, Inc. | 748K | $11.5T | 2.1% | ±0% |
| 9 | PRCT | Procept BioRobotics Corporation | 358K | $11.3T | 2.0% | ±0% |
| 10 | FATE | Fate Therapeutics, Inc. | 3.38M | $3.3T | 0.6% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE JOHNSON SIGNAL
AC read
JOHNSON & JOHNSON is a Other fund managing $334096.4 trillion in assets. The fund runs a focused portfolio of just 20 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q2 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed